There remains a critical need to develop new safe and effective antiviral agents active against the human pathogens, herpes simplex virus (HSV) and human cytomegalovirus (CMV). The broad long term objectives of this project are to identify, characterize, overexpress, and exploit novel targets for such drugs. The project takes a combined approach to drug development in which advantageous elements of traditional drug development approaches are combined with rational design. Novel drug targets are identified using resistance to previously existing drugs, the drug targets are characterized molecularly and overexpressed, and with the information gained used to design and screen new compounds. The first specific aim is to design novel drugs that target a well-established target, the HSV DNA polymerase (Pol), whose gene was first identified via drug resistance mutations. This enzyme interacts with a protein, UL42, which is required for polymerase processivity. Peptides derived from the portions of each protein involved in the interaction will be tested for their ability to disrupt Pol-UL42 complex formation and replicative activities. RNA molecules that bind to these portions of the protein will be derived using a new method and similarly tested. These compounds will be modified to generate potent inhibitors of HSV replication. The second specific aim begins with a novel drug target that is yet undefined, the CMV gene product that contributes to ganciclovir phosphorylation. The existence of this drug target has been inferred from studies of ganciclovir-resistant CMV mutants. The gene encoding this target will be mapped, cloned, characterized molecularly, and overexpressed. The information and reagents developed will be used to design and screen new inhibitors of CMV replication. The third specific aim begins with drugs for whom targets have not yet been assigned. These include drugs with activity against HSV, CMV, or both and drugs that potentiate the action of acyclovir against these viruses. Mutants resistant to these drugs will be isolated. The genes encoding each novel drug target will be mapped, cloned, characterized, molecularly, and overexpressed. The information and reagents developed will be used to design and screen new inhibitors of CMV replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI026077-07
Application #
3547098
Study Section
Special Emphasis Panel (SRC (50))
Project Start
1988-04-01
Project End
1995-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Sharma, Mayuri; Coen, Donald M (2014) Comparison of effects of inhibitors of viral and cellular protein kinases on human cytomegalovirus disruption of nuclear lamina and nuclear egress. J Virol 88:10982-5
Strang, Blair L; Boulant, Steeve; Kirchhausen, Tomas et al. (2012) Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments. MBio 3:
Strang, Blair L; Boulant, Steeve; Coen, Donald M (2010) Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J Virol 84:1771-84
Gentry, Brian G; Kamil, Jeremy P; Coen, Donald M et al. (2010) Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir. Antimicrob Agents Chemother 54:3093-8
Baltz, Jennifer L; Filman, David J; Ciustea, Mihai et al. (2009) The crystal structure of PF-8, the DNA polymerase accessory subunit from Kaposi's sarcoma-associated herpesvirus. J Virol 83:12215-28
Jiang, Changying; Komazin-Meredith, Gloria; Tian, Wang et al. (2009) Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity. J Virol 83:7573-80
Strang, Blair L; Sinigalia, Elisa; Silva, Laurie A et al. (2009) Analysis of the association of the human cytomegalovirus DNA polymerase subunit UL44 with the viral DNA replication factor UL84. J Virol 83:7581-9
Komazin-Meredith, Gloria; Santos, Webster L; Filman, David J et al. (2008) The positively charged surface of herpes simplex virus UL42 mediates DNA binding. J Biol Chem 283:6154-61
Hume, Adam J; Finkel, Jonathan S; Kamil, Jeremy P et al. (2008) Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function. Science 320:797-9
Loregian, Arianna; Coen, Donald M (2006) Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase. Chem Biol 13:191-200

Showing the most recent 10 out of 37 publications